## Abstract Sixtyโsix subjects diagnosed by validated criteria as having senile dementia of the Alzheimer type (SDAT) were assessed with clinical measures commonly used to study dementia. The severity of the SDAT was mild in 24, moderate in 24, and severe in 18. The data from these three groups in
Mild senile dementia of the alzheimer type: 2. Longitudinal assessment
โ Scribed by Dr. Leonard Berg; J. Philip Miller; Martha Storandt; Janet Duchek; John C. Morris; Eugene H. Rubin; William J. Burke; Lawrence A. Coben
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 761 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Milacemide, both an MAO-B inhibitor and a prodrug for glycine, has demonstrated cognitive enhancing effects in animal models, in cognitively intact young and elderly, and has been suggested as a potential treatment for senile dementia of the Alzheimer type (SDAT). This multicenter open-label trial e
Acetylcholinesterase (AChE) activity was measured in cerebrospinal fluid (CSF) samples from 36 individuals, including 12 persons with Alzheimer's disease, 12 normal controls, and 12 patients with other dementias. AChE activity also was measured in 47 normal subjects whose ages ranged from 20 to 84 t